However, SHOX2 mRNA expression was lower in breast invasive carcinoma (BRCA), acute myeloid leukemia (LAML), testicular germ cell tumors (TGCT), skin cutaneous melanoma (SKCM) and thyroid carcinoma (THCA) (Fig. 1A). Here, SHOX2 is linked to invasive breast carcinoma.